Compounded Tirzepatide

No manufacturer savings card available — compounded products are prepared by licensed 503A/503B pharmacies, not Eli Lilly.

NOT FDA-approved as finished drug. Compounded tirzepatide is permitted under FDA pharmacy compounding rules but is not reviewed for safety, efficacy or manufacturing quality by the FDA. The brand-name product Zepbound® is FDA-approved. FDA removed tirzepatide from the shortage list in late 2024; verify your provider sources only when clinically justified personalization rules apply.